140 related articles for article (PubMed ID: 12586225)
1. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
Kim HC; Shin CY; Seo DO; Jhoo JH; Jhoo WK; Kim WK; Shin EJ; Lee YH; Lee PH; Ko KH
Life Sci; 2003 Mar; 72(16):1883-95. PubMed ID: 12586225
[TBL] [Abstract][Full Text] [Related]
2. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
[TBL] [Abstract][Full Text] [Related]
3. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile.
Tortella FC; Robles L; Witkin JM; Newman AH
J Pharmacol Exp Ther; 1994 Feb; 268(2):727-33. PubMed ID: 8113984
[TBL] [Abstract][Full Text] [Related]
4. The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.
Shin EJ; Nah SY; Kim WK; Ko KH; Jhoo WK; Lim YK; Cha JY; Chen CF; Kim HC
Br J Pharmacol; 2005 Apr; 144(7):908-18. PubMed ID: 15723099
[TBL] [Abstract][Full Text] [Related]
5. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.
Shin EJ; Nabeshima T; Lee PH; Kim WK; Ko KH; Jhoo JH; Jhoo WK; Cha JY; Kim HC
Behav Brain Res; 2004 May; 151(1-2):267-76. PubMed ID: 15084442
[TBL] [Abstract][Full Text] [Related]
6. Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice.
Kim HC; Bing G; Jhoo WK; Kim WK; Shin EJ; Im DH; Kang KS; Ko KH
Life Sci; 2003 Jan; 72(7):769-83. PubMed ID: 12479976
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.
Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM
Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.
Tortella FC; Ferkany JW; Pontecorvo MJ
Life Sci; 1988; 42(24):2509-14. PubMed ID: 3374269
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice.
Dematteis M; Mallaret M; Baubichon D; Pernot-Marino I; Lallement G
Neurosci Lett; 1997 Oct; 234(2-3):91-4. PubMed ID: 9364505
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.
Shin EJ; Nah SY; Chae JS; Bing G; Shin SW; Yen TP; Baek IH; Kim WK; Maurice T; Nabeshima T; Kim HC
Neurochem Int; 2007 May; 50(6):791-9. PubMed ID: 17386960
[TBL] [Abstract][Full Text] [Related]
11. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
12. Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan.
Kim HC; Ko KH; Kim WK; Shin EJ; Kang KS; Shin CY; Jhoo WK
Behav Brain Res; 2001 May; 120(2):169-75. PubMed ID: 11182165
[TBL] [Abstract][Full Text] [Related]
13. N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats.
Witkin JM; Cerne R; Newman AH; Izenwasser S; Smith JL; Tortella FC
Pharmacol Biochem Behav; 2021 Apr; 203():173154. PubMed ID: 33609599
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.
Dematteis M; Lallement G; Mallaret M
Fundam Clin Pharmacol; 1998; 12(5):526-37. PubMed ID: 9794151
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 3-substituted 17-methylmorphinan analogs as potential anticonvulsant agents.
Newman AH; Bevan K; Bowery N; Tortella FC
J Med Chem; 1992 Oct; 35(22):4135-42. PubMed ID: 1433216
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
Leander JD
Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
[TBL] [Abstract][Full Text] [Related]
17. Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters.
Matsumoto RR; Hewett KL; Pouw B; Bowen WD; Husbands SM; Cao JJ; Newman AH
Neuropharmacology; 2001 Dec; 41(7):878-86. PubMed ID: 11684152
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
Loos WJ; de Graan AJ; de Bruijn P; van Schaik RH; van Fessem MA; Lam MH; Mathijssen RH; Wiemer EA
J Pharm Biomed Anal; 2011 Jan; 54(2):387-94. PubMed ID: 20926215
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors.
Nam Y; Shin EJ; Yang BK; Bach JH; Jeong JH; Chung YH; Park ES; Li Z; Kim KW; Kwon YB; Nabeshima T; Kim HC
Neurochem Int; 2012 Nov; 61(6):913-22. PubMed ID: 22326744
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effects of new morphinan derivatives.
Kim HC; Nabeshima T; Jhoo WK; Ko KH; Kim WK; Shin EJ; Cho M; Lee PH
Bioorg Med Chem Lett; 2001 Jul; 11(13):1651-4. PubMed ID: 11425529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
